July 2 (Reuters) -
* PRIMO BIOTECHNOLOGY SECURES A FUNDING AND TARGETS 2026 IPO
TO
STRENGTHEN GLOBAL RADIOPHARMACEUTICAL STRATEGY
* PRIMO BIOTECHNOLOGY CO: ANNOUNCED SUCCESSFUL COMPLETION OF
ITS
NT$220 MILLION SERIES A FUNDING ROUND
Source text: